Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS2 | Q9H2K2 | 17/20 | 0.64 |
| ▸ | WNT3A | P56704 | 11/20 | 0.64 |
| ▸ | TNKS | O95271 | 8/20 | 0.64 |
| ▸ | PARP1 | P09874 | 5/20 | 0.64 |
| ▸ | PARP2 | Q9UGN5 | 3/20 | 0.64 |
| ▸ | PARP3 | Q9Y6F1 | 2/20 | 0.64 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.64 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.64 |
| ▸ | AXIN2 | Q9Y2T1 | 1/20 | 0.64 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.48 |
| ▸ | SPR | P35270 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30870703 | 0.91 | TNKS2 (0.58) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL27436692 | 0.91 | TNKS2 (0.58) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL27436196 | 0.91 | TNKS2 (0.58) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL27436124 | 0.88 | TNKS2 (0.70) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL27436272 | 0.87 | TNKS2 (0.57) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL27436932 | 0.86 | TNKS2 (0.71) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL30870693 | 0.85 | TNKS2 (0.60) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL27436275 | 0.85 | TNKS2 (0.60) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL30870667 | 0.85 | TNKS2 (0.53) | TNKS2WNT3ATNKSPARP1PARP2 | |
| SCHEMBL27436693 | 0.85 | TNKS2 (0.53) | TNKS2WNT3ATNKSPARP1PARP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024086246-A2 | 2-SUBSTITUTED 3,4 A, 5, 7, 8, 8 A-HEXAHYDRO-4H-THIOP YRANO [4,3- DJPYRIMIDIN-4-ONES FOR WOUND TREATMENT | Eluciderm Inc. (US) | 2024-04-25 | — | — | WO | disclosed |
| WO-2024086246-A2 | 2-SUBSTITUTED 3,4 A, 5, 7, 8, 8 A-HEXAHYDRO-4H-THIOP YRANO [4,3- DJPYRIMIDIN-4-ONES FOR WOUND TREATMENT | Eluciderm Inc. (US) | 2024-04-25 | — | — | WO | disclosed |